BG102404A - Употреба на флупиртин за предпазване и лечение назаболявания, свързани с увреждане на хематопоетичната клетъчна система - Google Patents

Употреба на флупиртин за предпазване и лечение назаболявания, свързани с увреждане на хематопоетичната клетъчна система

Info

Publication number
BG102404A
BG102404A BG102404A BG10240498A BG102404A BG 102404 A BG102404 A BG 102404A BG 102404 A BG102404 A BG 102404A BG 10240498 A BG10240498 A BG 10240498A BG 102404 A BG102404 A BG 102404A
Authority
BG
Bulgaria
Prior art keywords
treatment
flupirtin
impairement
prevention
cellular system
Prior art date
Application number
BG102404A
Other languages
English (en)
Other versions
BG63149B1 (bg
Inventor
Gabriela Pergande
Werner Mueller
Original Assignee
VIATRIS Gmbh & Co.KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VIATRIS Gmbh & Co.KG filed Critical VIATRIS Gmbh & Co.KG
Publication of BG102404A publication Critical patent/BG102404A/bg
Publication of BG63149B1 publication Critical patent/BG63149B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Флупиртинът или неговите соли намират приложение като лекарствено средство за профилактика и лечение на заболявания, свързани с увреждане на хематопоетичната клетъчна система, например на лимфоцитите. Те могат да се прилагат и при лечението на пациенти, заразени с HIV, както и при заболели от СПИН.
BG102404A 1995-11-07 1998-04-24 Употреба на флупиртин за предпазване и лечение назаболявания, свързани с увреждане на хематопоетичната клетъчна система BG63149B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19541405A DE19541405A1 (de) 1995-11-07 1995-11-07 Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen, die mit einer Beeinträchtigung des hämatopoetischen Zellsystems einhergehen
PCT/DE1996/002009 WO1997017072A2 (de) 1995-11-07 1996-10-23 Verwendung von flupirtin zur prophylaxe und therapie von erkrankungen, die mit einer beeinträchtigung des hämatopoetischen zellsystems einhergehen

Publications (2)

Publication Number Publication Date
BG102404A true BG102404A (bg) 1998-12-30
BG63149B1 BG63149B1 (bg) 2001-05-31

Family

ID=7776799

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102404A BG63149B1 (bg) 1995-11-07 1998-04-24 Употреба на флупиртин за предпазване и лечение назаболявания, свързани с увреждане на хематопоетичната клетъчна система

Country Status (27)

Country Link
US (2) US6034111A (bg)
EP (1) EP0859613B1 (bg)
JP (1) JPH11514652A (bg)
KR (1) KR100512673B1 (bg)
CN (1) CN1116037C (bg)
AT (1) ATE316789T1 (bg)
AU (1) AU711207B2 (bg)
BG (1) BG63149B1 (bg)
BR (1) BR9611588A (bg)
CA (1) CA2189705C (bg)
CZ (1) CZ298115B6 (bg)
DE (2) DE19541405A1 (bg)
DK (1) DK0859613T3 (bg)
ES (1) ES2257755T3 (bg)
HK (1) HK1016508A1 (bg)
HU (1) HU225742B1 (bg)
MX (1) MX9803610A (bg)
NO (1) NO315074B1 (bg)
NZ (1) NZ330414A (bg)
PL (1) PL186537B1 (bg)
PT (1) PT859613E (bg)
RU (1) RU2200555C2 (bg)
SK (1) SK284601B6 (bg)
TW (1) TW393317B (bg)
UA (1) UA51682C2 (bg)
WO (1) WO1997017072A2 (bg)
ZA (1) ZA968783B (bg)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19625582A1 (de) * 1996-06-27 1998-01-02 Asta Medica Ag Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen die mit einer unphysiologisch hohen Zellsterberate einhergehen
US6821995B1 (en) 1999-12-01 2004-11-23 Duke University Method of treating batten disease
DE10327674A1 (de) 2003-06-20 2005-01-05 Awd.Pharma Gmbh & Co. Kg Injizierbare Darreichungsform von Flupirtin
EP1688141A1 (en) * 2005-01-31 2006-08-09 elbion AG The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome
US20080279930A1 (en) * 2007-05-07 2008-11-13 Bernd Terhaag Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
DE102009023162B4 (de) * 2009-05-29 2011-07-07 Corden PharmaChem GmbH, 68305 Verfahren zur Herstellung von Flupirtin
EP2462253B1 (en) * 2009-08-07 2021-04-07 Swagelok Company Low temperature carburization under soft vacuum
DE102010030053A1 (de) 2010-06-14 2011-12-15 Awd.Pharma Gmbh & Co.Kg Injizierbare Darreichungsform von Flupirtin
MX2014010460A (es) * 2012-03-02 2014-10-13 Meda Pharma Gmbh & Co Kg Formulaciones farmaceuticas que contienen flupirtina.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN172468B (bg) * 1990-07-14 1993-08-14 Asta Medica Ag
DE4327516A1 (de) * 1993-08-17 1995-02-23 Asta Medica Ag Primäre und sekundäre neuroprotektive Wirkung bei neurodegenerativen Erkrankungen von Flupirtin

Also Published As

Publication number Publication date
RU2200555C2 (ru) 2003-03-20
NO981898D0 (no) 1998-04-27
ATE316789T1 (de) 2006-02-15
HU225742B1 (en) 2007-07-30
DK0859613T3 (da) 2006-06-06
BG63149B1 (bg) 2001-05-31
TW393317B (en) 2000-06-11
CN1116037C (zh) 2003-07-30
EP0859613A2 (de) 1998-08-26
HUP9901659A2 (hu) 1999-09-28
NO315074B1 (no) 2003-07-07
DE59611327D1 (de) 2006-04-13
HK1016508A1 (en) 1999-11-05
WO1997017072A3 (de) 1997-07-24
EP0859613B1 (de) 2006-02-01
SK58698A3 (en) 1998-09-09
CA2189705C (en) 2005-08-09
AU711207B2 (en) 1999-10-07
BR9611588A (pt) 1999-04-06
PL326629A1 (en) 1998-10-12
CZ298115B6 (cs) 2007-06-27
ZA968783B (en) 1997-05-27
CA2189705A1 (en) 1997-05-08
CZ128398A3 (cs) 1998-09-16
ES2257755T3 (es) 2006-08-01
WO1997017072A2 (de) 1997-05-15
HUP9901659A3 (en) 2001-04-28
PL186537B1 (pl) 2004-01-30
US6034111A (en) 2000-03-07
CN1201391A (zh) 1998-12-09
PT859613E (pt) 2006-06-30
NZ330414A (en) 1999-10-28
SK284601B6 (sk) 2005-07-01
AU1716597A (en) 1997-05-29
MX9803610A (es) 1998-09-30
KR19990067366A (ko) 1999-08-16
KR100512673B1 (ko) 2005-12-09
DE19541405A1 (de) 1997-05-15
UA51682C2 (uk) 2002-12-16
JPH11514652A (ja) 1999-12-14
US6034112A (en) 2000-03-07
NO981898L (no) 1998-04-27

Similar Documents

Publication Publication Date Title
ES2125233T3 (es) Tratamiento de las infecciones retrovirales humanas con 2',3'-didesoxiinosina.
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
BG101118A (bg) Лечебни съединения
TR199901174T2 (xx) Yeni heterosiklilmetil-ikameli pirazol t�revleri.
NO954996L (no) Anvendelse av nona- og dekapeptider for fremstilling av et legemiddel for behandling av AIDS
PT763037E (pt) Derivados de pirrol ¬a|-anelizados e sua utilizacao farmaceutica
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
NO972391D0 (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
SE9101815D0 (sv) Behandling av sjukdom foerbunden med hiv-infektioner
ATE182271T1 (de) Arzneimittel zur behandlung von krebs, aids und viruserkrankungen
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
BG102404A (bg) Употреба на флупиртин за предпазване и лечение назаболявания, свързани с увреждане на хематопоетичната клетъчна система
AU2861389A (en) Disubstituted pyridines
FI935780A (fi) HIV-proteaasin inhibiittoreita, jotka ovat hyödyllisiä AIDSin hoitoa varten
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
AU1604592A (en) New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
DE69606777D1 (de) Naphthamidderivate von 3-beta-amino azabicyclooctan oder nonan als antipsychotische arzneimittel
UA41338C2 (uk) Спосіб інгібування ретровірусної інфекції, яка викликана вірусом імунодефіциту людини (віл), спосіб інгібування вірусу імунодефіциту людини (віл)
AU2396900A (en) Treatment and prevention of hiv and other viral infections
HU9300349D0 (en) Method for producing dibenzo- or benzo-pyrido-cyclohepta-piperidine derivatives or piperidylidene or piperazine derivatives thereof as well as pharmaceutical preparatives contqining them
AU660916B2 (en) Beta-hydroxamate D-aspartic acid for treatment of viral infections and tumours
PL322847A1 (en) Condensed b-carbolins
RU93055681A (ru) Ингибиторы вич-протеазы, способ их получения, их использование в фармкомпозициях
IT8919204A0 (it) Composizione per la prevenzione e la cura di parodontopatte.